Glanbia (GLAPF) to Announce Quarterly Earnings on Thursday

Glanbia (OTCMKTS:GLAPFGet Free Report) is projected to release its resultson Thursday, August 6th. Analysts expect Glanbia to announce earnings of $0.7010 per share and revenue of $2.0162 billion for the quarter.

Glanbia Price Performance

Glanbia stock opened at $26.00 on Thursday. The company has a fifty day moving average price of $26.24 and a two-hundred day moving average price of $22.30. Glanbia has a 12 month low of $15.99 and a 12 month high of $28.81.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Glanbia in a research report on Friday, June 26th. Barclays reaffirmed an “overweight” rating on shares of Glanbia in a research report on Wednesday, June 17th. Finally, Oddo Bhf cut shares of Glanbia to a “neutral” rating in a report on Wednesday, July 15th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Glanbia presently has an average rating of “Moderate Buy”.

Get Our Latest Stock Report on Glanbia

About Glanbia

(Get Free Report)

Glanbia plc is a global nutrition group headquartered in Kilkenny, Ireland, with roots tracing back to the merger of Avonmore and Waterford agricultural cooperatives in 1997. The company is organized around two main divisions: Performance Nutrition, which focuses on sports and lifestyle-forward consumer products, and Glanbia Nutritionals, which supplies nutritional ingredients and custom formulation services to food, beverage and pharmaceutical customers.

Under its Performance Nutrition arm, Glanbia markets well-known brands of protein powders, bars and ready-to-drink beverages designed for athletes, fitness enthusiasts and wellness-focused consumers.

Recommended Stories

Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.